|
DDB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.674200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.877600E-01 |
| Normal-vs-Stage2 |
3.189800E-01 |
| Normal-vs-Stage3 |
5.485800E-01 |
| Normal-vs-Stage4 |
3.976200E-01 |
| Stage1-vs-Stage2 |
3.853600E-01 |
| Stage1-vs-Stage3 |
1.933360E-01 |
| Stage1-vs-Stage4 |
1.916210E-01 |
| Stage2-vs-Stage3 |
9.782100E-02 |
| Stage2-vs-Stage4 |
9.885600E-02 |
| Stage3-vs-Stage4 |
7.532600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.960400E-01 |
| Normal-vs-AfricanAmerican |
1.925220E-01 |
| Normal-vs-Asian |
8.512400E-01 |
| Caucasian-vs-AfricanAmerican |
1.995580E-01 |
| Caucasian-vs-Asian |
7.350600E-01 |
| AfricanAmerican-vs-Asian |
1.818380E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.255600E-01 |
| Normal-vs-Female |
7.500800E-01 |
| Male-vs-Female |
4.588400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.628400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.837800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.321200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.091800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.153800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.448800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.224600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.451200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.479400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.846800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.634600E-01 |
| Classical-VS-Follicular |
3.462400E-02 |
| Classical-VS-Other |
2.264200E-01 |
| Classical-VS-Normal |
3.982200E-01 |
| Tall-VS-Follicular |
6.742200E-01 |
| Tall-VS-Other |
4.564400E-01 |
| Tall-VS-Normal |
8.244400E-01 |
| Follicular-VS-Other |
6.692200E-01 |
| Follicular-VS-Normal |
4.187600E-01 |
| Other-VS-Normal |
3.523800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.604000E-01 |
| Normal-vs-N1 |
1.196820E-01 |
| N0-vs-N1 |
8.011600E-02 |
|
|
